Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Interactions Among Different Genetic Loci in Age-Related Macular Degeneration Publisher Pubmed



Bonyadi M1 ; Jabbarpoor Bonyadi MH2 ; Yaseri M3 ; Soheilian M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Center of Excellence for Biodiversity, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
  2. 2. Ocular Tissue Engineering Research Center, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of biostatistics and epidemiology, Tehran University of Medical Sciences, Tehran, Iran

Source: Ophthalmic Genetics Published:2018


Abstract

Purpose: To evaluate the possible synergistic effect of at risk genotypes of ARMS2/LOC387715 (A69S), DNA repair SMUG1 rs3087404, CCL2–2518, C3 (R102G), CFH Y402H, complement factor B (L9H), and complement factor I (CFI) (G119R) in advanced age-related macular degeneration compared to those of healthy controls. Elucidation of synergistic effects between different genetic loci may clarify their pathogenetic pathways. Methods: We calculated relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S) to estimate the additive or supra-additive effects of the mentioned genotypes. Results: ARMS2-CFH [RERI = 4.78 (95% CI 2.17–10.61), AP = 0.65 (95% CI 0.33–0.83), S = 4.11 (95% CI 1.40–12.06)], and CFH-C3 combinations [RERI = 2.71 (95% CI 0.04–7.01) AP = 0.47 (95% CI −0.03–0.7) S = 2.30 (95%CI 0.97–5.45)] have the most significant levels of synergism and C3-CFI combination [RERI = −1.65 (95%CI −4.34–0.06), AP = −0.92(95%CI −3.09–−0.09), S = 0.32 (95%CI 0.09 = 1.20)] has the most significant level of antagonism. Conclusion: Among different genotype combinations ARMS2-CFH and CFH-C3 combinations have the most significant levels of synergism and C3-CFI combination has the most significant level of antagonism in AMD patients. © 2017 Taylor & Francis.
Experts (# of related papers)